Literature DB >> 14659775

Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations.

Tommaso Sanna1, Antonio Dello Russo, Daniela Toniolo, Michal Vytopil, Gemma Pelargonio, Giuseppe De Martino, Enzo Ricci, Gabriella Silvestri, Vincenzo Giglio, Loredana Messano, Elisabetta Zachara, Fulvio Bellocci.   

Abstract

AIMS: Retrospective studies have identified a mutation in the lamin A/C (LMNA) gene in patients selected on the basis of a phenotype characterized by dilated cardiomyopathy, atrioventricular conduction disturbances and sudden death. However, the features of cardiac abnormalities in patients with an initial diagnosis of Emery-Dreifuss muscular dystrophy (EDMD) are poorly known. Aim of the present study was to investigate the spectrum of cardiac disease in patients with an initial diagnosis of EDMD caused by a mutation in the LMNA gene. METHODS AND
RESULTS: Ten consecutive patients with EDMD and a LMNA gene mutation were evaluated with structured medical interview, physical examination, ECG, echocardiogram and 24-h Holter monitoring. Electrophysiological testing and cardiac catheterization were performed if a class 1 or 2 American Heart Association guidelines indication was present. Cardiac disease was found in eight of 10 patients and consisted in the variable combination of supraventricular arrhythmias, disorders of atrioventricular conduction, ventricular arrhythmias, dilated cardiomyopathy, non-dilated cardiomyopathy, restrictive cardiomyopathy and sudden death despite pacemaker implant.
CONCLUSIONS: Cardiac disease is common in patients with an initial diagnosis of EDMD caused by a mutation in the LMNA gene and consists of arrhythmias, disorders of atrioventricular conduction, cardiomyopathies and sudden death despite pacemaker implant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659775     DOI: 10.1016/j.ehj.2003.09.020

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

Review 2.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

3.  Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

Review 4.  Beyond membrane channelopathies: alternative mechanisms underlying complex human disease.

Authors:  Konstantinos Dean Boudoulas; Peter J Mohler
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

5.  A novel de novo mutation in Lamin A/C gene in Emery Dreifuss Muscular Dystrophy patient with atrial paralysis.

Authors:  Chaerul Achmad; Almira Zada; Mardlatillah Affani; Mohammad Iqbal; Erwan Martanto; Augustine Purnomowati; Toni M Aprami
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 6.  Mitogen-activated protein kinase inhibitor regulation of heart function and fibrosis in cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Antoine Muchir; Wei Wu; Howard J Worman
Journal:  Trends Cardiovasc Med       Date:  2010-10       Impact factor: 6.677

7.  Widening gap in age at muscular dystrophy-associated death between blacks and whites, 1986-2005.

Authors:  Aileen Kenneson; Ajay Vatave; Richard Finkel
Journal:  Neurology       Date:  2010-09-14       Impact factor: 9.910

8.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

9.  Nesprin-1 mutations in human and murine cardiomyopathy.

Authors:  Megan J Puckelwartz; Eric J Kessler; Gene Kim; Megan M Dewitt; Yuan Zhang; Judy U Earley; Frederic F S Depreux; James Holaska; Stephanie K Mewborn; Peter Pytel; Elizabeth M McNally
Journal:  J Mol Cell Cardiol       Date:  2009-11-24       Impact factor: 5.000

10.  Three new cases of dilated cardiomyopathy caused by mutations in LMNA gene.

Authors:  Larysa N Sivitskaya; Nina G Danilenko; Tatiyana G Vaikhanskaya; Tatsiyana V Kurushka; Oleg G Davydenko
Journal:  Acta Myol       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.